MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 541 to 560 of 5,858 approvalsPage 28 of 293

THYROCORD 50 TABLET 50 MCG

Approval Number: SIN16696P
Approval: Feb 15, 2023

THYROCORD 75 TABLET 75 MCG

Approval Number: SIN16695P
Approval: Feb 15, 2023

THYROCORD 100 TABLET 100 MCG

Approval Number: SIN16694P
Approval: Feb 15, 2023

SAQUIN SR PROLONGED-RELEASE TABLETS 50MG

Approval Number: SIN16689P
Approval: Feb 14, 2023

SAQUIN SR PROLONGED-RELEASE TABLETS 300MG

Approval Number: SIN16692P
Approval: Feb 14, 2023

SAQUIN SR PROLONGED-RELEASE TABLETS 150mg

Approval Number: SIN16690P
Approval: Feb 14, 2023

SAQUIN SR PROLONGED-RELEASE TABLETS 400MG

Approval Number: SIN16693P
Approval: Feb 14, 2023

SAQUIN SR PROLONGED-RELEASE TABLETS 200MG

Approval Number: SIN16691P
Approval: Feb 14, 2023

ARIPDON Tablets 5mg

Approval Number: SIN16688P
Approval: Feb 13, 2023

RINVOQ EXTENDED-RELEASE TABLET 45MG

Approval Number: SIN16687P
Approval: Feb 10, 2023

MAXIGRA 100 FILM-COATED TABLETS 100MG

Approval Number: SIN16684P
Approval: Feb 6, 2023

FESPIXON CREAM

Approval Number: SIN16683P
Approval: Jan 31, 2023

DIMETRUM TABLET 2MG

Approval Number: SIN16682P
Approval: Jan 26, 2023

VIENOMET TABLETS 2MG

Approval Number: SIN16681P
Approval: Jan 25, 2023

DALISOON F.C. TABLETS 5MG

Approval Number: SIN16679P
Approval: Jan 18, 2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.